Avinger Announces First-in-Patient use of Extended Nosecone Version of Next Generation Pantheris
Avinger, Inc. (AVGR)
Last avinger, inc. earnings: 8/8 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.avinger.com
Company Research
Source: GlobeNewswire
REDWOOD CITY, Calif., March 29, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that Arne Schwindt, M.D., a vascular surgeon at St. Franziskus Hospital in Münster, Germany, successfully treated the first three patients with the extended nosecone version of the next generation Pantheris Lumivascular atherectomy system (A400EX). This product is a line extension of the existing next generation platform, with a longer nosecone that enhances the plaque removal capacity of the device in addition to the feature improvements of the next generation of devices. This new device qualifies for commercial sale in the European Union (EU) under the existing CE Marking for Pantheris. The extended nosecone increases the storage capacity of the Pantheris system by approximately 75%, which should translate to increased procedural efficiency, particularly in long, diffuse lesions with significant pla
Show less
Read more
Impact Snapshot
Event Time:
AVGR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AVGR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AVGR alerts
High impacting Avinger, Inc. news events
Weekly update
A roundup of the hottest topics
AVGR
News
- Avinger, Inc. (NASDAQ: AVGR) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Avinger, Inc. (NASDAQ: AVGR) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Avinger, Inc. (NASDAQ: AVGR) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Avinger, Inc. (NASDAQ: AVGR) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Avinger, Inc. (NASDAQ: AVGR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.MarketBeat
AVGR
Analyst Actions
- 3/21/24 - HC Wainwright
AVGR
Sec Filings
- 4/15/24 - Form EFFECT
- 4/12/24 - Form DEFA14A
- 4/12/24 - Form DEF
- AVGR's page on the SEC website